LB Pharmaceuticals Inc. announced the appointment of Robert Lenz, M.D., Ph.D. to its Board of Directors. Dr. Robert Lenz is a veteran research and development leader, currently advising several biopharmaceuticals companies. Most recently, he served as the Executive Vice President and Head of Research and Development at Neumora Therapeutics, and prior to that, he spent over a decade at Amgen Inc. in key leadership roles, including Senior Vice President, Head of Global Development.
Earlier in his career, Dr. Lenz held positions of increasing responsibility at Abbott Laboratories, ultimately serving as Divisional Vice President for Neuroscience, Anesthesia, and Psychiatry Development. Throughout his career, Dr. Lenz has overseen the development of multiple medicines through regulatory approval. He also serves on the board and scientific boards of several companies.
Dr. Lenz earned his M.D. and Ph.D. with honors from the University of Maryland School of Medicine and completed his neurology residency at the University of California - Los Angeles. He holds a bachelor's degree from Dickinson College and has been recognized with multiple awards for innovation and leadership in the pharmaceutical industry.
